Recent Updates
Recently added Catalysts
MYO Positive Sentiment

Myomo to Report Fourth Quarter Financial Results on March 7, 2024

Thursday, February 29, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Myomo, Inc. will report its financial results for the fourth quarter and fiscal year ended December 31, 2023, on March 7, 2024. The company specializes in wearable medical robotics aimed at improving functionality for individuals with neurological disorders and upper-limb paralysis. This announcement reflects Myomo's commitment to transparency and ongoing operations.
Price reaction · baseline $3.08 (2024-02-29T16:04:00.000Z) · hit during market hours · 2 other MYO headline(s) in the window, move may be shared
day 0 close · peak
-0.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Myomo is set to report its fourth quarter financial results.
  • The company focuses on wearable medical robotics for neurological disorders.
  • The announcement indicates ongoing business activity and transparency.

Full Press Release Details

BOSTON (February 29, 2024) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the fourth quarter and fiscal year ended December 31, 2023 on March 7, 2024. Read More .

Frequently Asked Questions

When will Myomo report its financial results?

Myomo will report its financial results on March 7, 2024.

What fiscal year results will Myomo announce?

Myomo will announce results for the fiscal year ended December 31, 2023.

What does Myomo specialize in?

Myomo specializes in wearable medical robotics for neurological disorders.

ShareAdd on Google
Tags: MYO Viatris Investor Conferences Healthcare Myomo financial results wearable robotics neurological disorders
Last updated: Feb 29, 2024

Biotech snapshot

Cash runway
$13M liquidity · $1M/mo burn
~20 mo
Low dilution risk